ArticleCancers2025

Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcinoma.

Kazuya Yasui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.